Literature DB >> 23134507

Validation of robust tools to measure sialorrhea in amyotrophic lateral sclerosis: a study in a large French cohort.

Maya Abdelnour-Mallet1, Sophie Tezenas Du Montcel, Pamela A Cazzolli, Avi Assouline, Christine Pointon, Nathalie Leveque, Henri Dominique, Hassan Elmazria, Michaela Rothmayer, Timothee Lenglet, Gaelle Bruneteau, Nadine le Forestier, Sylvie Delanian, Jesus Gonzalez-Bermejo, François Salachas, Benjamin Rix Brooks, Pierre François Pradat.   

Abstract

There is an unmet need for validated tools to measure sialorrhea in amyotrophic lateral sclerosis, especially to evaluate treatments. We assessed the inter-/intra-rate reviewer reliability of two scales: the Oral Secretion Scale (OSS), specifically developed for ALS patients, and the Sialorrhea Scoring Scale (SSS), initially developed for Parkinson's disease patients. Sialorrhea was rated in 69 ALS consecutive patients by four evaluators: two neurologists, one nurse and one speech therapist. Inter-rater reliability was evaluated by the light kappa coefficient and intra-rater reliability by the weighted kappa coefficient. We also compared patients' and caregivers' answers. Results demonstrated that the two scales present a high inter-/intra-rater reliability: weighted kappas were 0.85 for both scales and light kappas 0.89 for the OSS and 0.88 for the SSS. Both scales also showed a good intra-profession reliability (OSS kappa = 0.84; SSS kappa = 0.79) and agreement between patients' and caregivers' answers. The SSS showed a higher responsiveness compared to OSS. In conclusion, both Oral Secretion Scale and Sialorrhea Scoring Scale are reliable tools to measure sialorrhea in ALS patients. Because of the wide range of salivation degrees, SSS may be more sensitive as a tool to evaluate treatments in patients with severe hypersialorrhea.

Entities:  

Mesh:

Year:  2012        PMID: 23134507     DOI: 10.3109/21678421.2012.735238

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  5 in total

1.  Radiotherapy treatment of sialorrhea in patients with amyotrophic lateral sclerosis requiring non-invasive ventilation.

Authors:  Maria del Mar Amador; Avi Assouline; Jésus Gonzalez-Bermejo; Pierre-François Pradat
Journal:  J Neurol       Date:  2015-07-15       Impact factor: 4.849

2.  Electrical impedance myography in the evaluation of the tongue musculature in amyotrophic lateral sclerosis.

Authors:  Sanjana Shellikeri; Yana Yunusova; Jordan R Green; Gary L Pattee; James D Berry; Seward B Rutkove; Lorne Zinman
Journal:  Muscle Nerve       Date:  2015-06-03       Impact factor: 3.217

3.  The Prevalence and Management of Saliva Problems in Motor Neuron Disease: A 4-Year Analysis of the Scottish Motor Neuron Disease Register.

Authors:  Iona Pearson; Stella A Glasmacher; Judith Newton; Emily Beswick; Arpan R Mehta; Richard Davenport; Siddharthan Chandran; Suvankar Pal
Journal:  Neurodegener Dis       Date:  2021-04-26       Impact factor: 2.977

Review 4.  Clinical Measures of Bulbar Dysfunction in ALS.

Authors:  Yana Yunusova; Emily K Plowman; Jordan R Green; Carolina Barnett; Peter Bede
Journal:  Front Neurol       Date:  2019-02-19       Impact factor: 4.003

5.  Developing an intrasalivary gland botox service for patients receiving long-term non-invasive ventilation at home: a single-centre experience.

Authors:  Jessica Harbottle; Hannah Carlin; Thomas Payne-Doris; Hilary M I Tedd; Anthony de Soyza; Ben Messer
Journal:  BMJ Open Respir Res       Date:  2022-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.